Lamivudine resistance inimmunocompetent chronic hepatitis B
- 31 July 1997
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 26 (6), 1393-1395
- https://doi.org/10.1016/s0168-8278(97)80476-x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Selection of Mutations in the Hepatitis B Virus Polymerase During Therapy of Transplant Recipients With LamivudineHepatology, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Viral Resistance and the Selection of Antiretroviral CombinationsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
- High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptaseAntimicrobial Agents and Chemotherapy, 1993
- Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytesAntimicrobial Agents and Chemotherapy, 1992
- Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.Proceedings of the National Academy of Sciences, 1991